Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Tiankui ShuaiPeijing YanHuaiyu XiongQiangru HuangLei ZhuKe-Hu YangJian LiuPublished in: BioMed research international (2019)
Monitoring suPAR concentrations may be used for early diagnosis and prognosis for patients with CKD, and the higher suPAR increased the risk of mortality, cardiovascular events, and end-stage renal disease.